Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Still, the medications in the latest round of negotiations — which now includes “Part B” drugs given in doctors offices — ...

Explore the potential of the HIV drug Maraviroc in slowing glioblastoma growth as discovered by McMaster University ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

Decoding the complex communication system of the deadliest brain cancer has revealed that an already approved HIV drug could ...

DE BILT, Netherlands & GLASGOW, Scotland--(BUSINESS WIRE)--Code Pharma today announced positive eight-week results for human immunodeficiency virus (HIV)-drug Gammora®, showing potential to cure HIV ...

HOUSTON, Texas (KTRK) -- The Food and Drug Administration is currently reviewing a first-of-its-kind, twice-yearly injectable medication that experts say could revolutionize HIV prevention. The drug, ...

Over the past three decades, there have been amazing advances in treating and preventing HIV. Subscribe to our newsletter for the latest sci-tech news updates. It's now a manageable infection. A ...

The immune system remains seriously out-of-whack—in an inflammatory state of overactivation and impaired ...